Archived News for Health Sector Professionals
Official data suggests New South Wales is facing a severe shortage of nursing staff.
Studies show painkiller risks
Two new studies have shed light on the impacts of two of the most common painkillers.
Tamper-proof opioids reviewed
Tamper-proof opioids may have stopped people injecting them, but have not slowed the epidemic.
Teen weed, drink and smokes drop
The consumption of alcohol, tobacco and marijuana has dropped among Australian teenagers.
High-tech pill passes human trials
Australian researchers are running human trials of a gas-sensing swallowable capsule.
$100 million for mental health
The Federal Government has put up over $100 million for school mental health programs and new Headspace centres.
Hospital culture detailed
An internal report has revealed a "toxic" and "demoralising" culture of bullying and mismanagement at Victoria’s South West Healthcare hospital.
Hunt launches health cost probe
Health minister Greg Hunt has announced an expert committee to look into exorbitant out-of-pocket medical expenses.
Antibiotic alternatives needed
Experts say we need alternatives to antibiotics to allow them to remain useful in fighting more serious ones.
CRISPR fix for hearing
Scientists in the US and China have successfully restored hearing in a mouse model of human genetic deafness.
Immune blueprint uncovered
Australian researchers say they have found a molecular ‘blueprint’ for the immune system’s ability to fight disease by ‘remembering’ infections.
Industrial effects roll on
New research suggests the ill-effects of the Industrial Revolution are still being felt 200 years later.
EJA wants gas standards raised
Experts have warned that Australians are being placed at risk by government inaction on dangerous pollutants.
Research follows internal words
New research shows having an internal monologue could be fundamentally the same as speaking thoughts out loud.
Union rejects ambulance review
A review has found the NT St John Ambulance service to be satisfactory, but the paramedics’ union disagrees.
ACCC chases Novartis pain claims
The ACCC is taking GlaxoSmithKline (GSK) and Novartis to the Federal Court over “false or misleading” pain medication marketing.